Intellia Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Intellia Therapeutics, Inc. Website Screenshot

http://www.intelliatx.com

Intellia Therapeutics, Inc. Company Intro

Using CRISPR/Cas9 technology, Intellia Therapeutics is developing revolutionary genome editing therapies to cure genetic diseases with simple, targeted treatments.

Industry

Healthcare

Intellia Therapeutics, Inc. Headquaters

40 Erie Street
Cambridge,02139
United States


Intellia Therapeutics, Inc. Share price

14 Dec 2021 17:57 GMT

$111.30

-2.95 (-2.58 %)


Intellia Therapeutics, Inc. Market cap

$7.6 B


WMC RANKING

2022

Intellia Therapeutics, Inc. # 88

Biotechnology

Latest Intellia Therapeutics, Inc. News

News 06 Jan 2022

Intellia Therapeutics Highlights Strategic Priorities and Anticipated Development Milestones for 2022

Advance clinical development of NTLA-2001, a potential single-dose therapy for transthyretin (ATTR) amyloidosis; on track to present additional data from...

News 06 Jan 2022

Intellia Therapeutics Inc. (NASDAQ:NTLA) Will Likely Reach 238.00 USD!

Intellia Therapeutics Inc. (NASDAQ:NTLA) shares, rose in value on Wednesday, January 05, with the stock price down by -8.97% to the previous day's close as...

News 06 Jan 2022

Intellia plans to advance several new gene editing candidates in 2022

Gene editing biotech Intellia Therapeutics says it plans to nominate several new development candidates this year.The company expects to advance at least...


WMC Market Score


WMC Market to Revenue Score


Intellia Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Intellia Therapeutics, Inc. USD $51,523 $201,483 $-148,630 $76,000B 88
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $713,370B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $539,620B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,540B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Intellia Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Intellia Therapeutics, Inc. Post vs Top 4 Industry Competitors




Intellia Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Intellia Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Intellia Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Intellia Therapeutics, Inc. 0.56 13.21 47.16 0 0 0 27.22
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries